{"doi":"10.1111/cup.13689","title":"Germline mutations predisposing to melanoma","abstract":"<jats:title>Abstract</jats:title><jats:p>Nearly 15% of melanomas occur in patients with a family history and a subset of these patients have a germline mutation in a melanoma predisposing gene. <jats:italic>CDKN2A</jats:italic> mutations are responsible for the majority of hereditary melanoma, but many other susceptibility genes have been discovered in recent years, including <jats:italic>CDK4</jats:italic>, <jats:italic>TERT</jats:italic>, <jats:italic>ACD</jats:italic>, <jats:italic>TERF2IP</jats:italic>, <jats:italic>POT1</jats:italic>, <jats:italic>MITF</jats:italic>, <jats:italic>MC1R</jats:italic>, and <jats:italic>BAP1</jats:italic>. Additionally, melanoma risk is increased in mixed cancer syndromes caused by mutations in <jats:italic>PTEN</jats:italic>, <jats:italic>BRCA2</jats:italic>, <jats:italic>BRCA1</jats:italic>, <jats:italic>RB1</jats:italic>, and <jats:italic>TP53</jats:italic>. While early onset, multiple tumors, and family cancer history remain the most valuable clinical clues for hereditary melanoma, characteristic epithelioid cytology of melanocytic tumors may suggest an underlying <jats:italic>BAP1</jats:italic> mutation. Herein, we review the clinical and histopathologic characteristics of melanocytic tumors associated with these germline mutations and discuss the role of genetic counseling.</jats:p>","journal":"Journal of Cutaneous Pathology","year":2020,"id":24560,"datarank":2.6292786102647483,"base_score":4.6913478822291435,"endowment":4.6913478822291435,"self_citation_contribution":0.7037021823343717,"citation_network_contribution":1.9255764279303764,"self_endowment_contribution":0.7037021823343717,"citer_contribution":1.9255764279303764,"corpus_percentile":null,"corpus_rank":null,"citation_count":108,"citer_count":108,"citers_with_citation_signal":75,"citers_with_endowment":75,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":147015,"name":"Nicole Mans","orcid":"0000-0003-4173-5022","position":1,"is_corresponding":false},{"id":147016,"name":"Jeanna Welborn","orcid":null,"position":2,"is_corresponding":false},{"id":147017,"name":"Maija Kiuru","orcid":"0000-0002-7010-5516","position":3,"is_corresponding":false},{"id":147014,"name":"Atrin Toussi","orcid":"0000-0003-2925-3418","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.6913478822291435,"endowment":4.6913478822291435,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"32249949","pmcid":"PMC8232041","openalex_id":"https://openalex.org/W3014918546","authors":[],"funders":[{"funder_name":"Foundation for the National Institutes of Health","grant_id":"K23AR074530","title":null},{"funder_name":"National Institutes of Health","grant_id":"5K23AR074530-04","title":"Molecular basis of melanocytic nevi"},{"funder_name":"Dermatology Foundation","grant_id":"","title":null},{"funder_name":"Dermatology Foundation","grant_id":"","title":null}],"total_grants":4,"fwci":4.5166,"citation_percentile":0.95968231,"influential_citations":6,"citation_trend":[{"year":2020,"count":1},{"year":2021,"count":9},{"year":2022,"count":16},{"year":2023,"count":27},{"year":2024,"count":30},{"year":2025,"count":16},{"year":2026,"count":8}],"oa_status":"bronze","license":"Wiley Online Library User Agreement","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.13689","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.13689","host_type":"BRONZE"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cup.13689","host_type":"publisher"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcup.13689","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/cup.13689","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cup.13689","host_type":"publisher"},{"url":"https://doi.org/10.1111/cup.13689","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/32249949","host_type":"repository"},{"url":"https://escholarship.org/uc/item/1jz7b7f1","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8232041","host_type":"repository"},{"url":"https://dx.doi.org/10.1111/cup.13689","host_type":""},{"url":"https://doi.org/https://doi.org/10.1111/cup.13689","host_type":""}],"fields_of_study":["Cutaneous Melanoma Detection and Management","Melanoma and MAPK Pathways","melanin and skin pigmentation","Medicine","Biology","03 medical and health sciences","0302 clinical medicine","Adolescent","Adult","Aged","Aged, 80 and over","Cyclin-Dependent Kinase 4","Cyclin-Dependent Kinase Inhibitor p16","Genes, p16","Genetic Predisposition to Disease","Germ-Line Mutation","Humans","Melanoma","Microphthalmia-Associated Transcription Factor","Middle Aged","Nevus, Pigmented","Phenotype","Receptor, Melanocortin, Type 1","Shelterin Complex","Telomerase","Telomere-Binding Proteins","Tumor Suppressor Proteins","Ubiquitin Thiolesterase","Young Adult"],"mesh_terms":["Shelterin Complex","Adolescent","Adult","Aged","Aged, 80 and over","Humans","Melanoma","Middle Aged","Nevus, Pigmented","Phenotype","Germ-Line Mutation","Telomerase","Cyclin-Dependent Kinase Inhibitor p16","Genes, p16","Genetic Predisposition to Disease","Tumor Suppressor Proteins","Telomere-Binding Proteins","Ubiquitin Thiolesterase","Receptor, Melanocortin, Type 1","Cyclin-Dependent Kinase 4","Microphthalmia-Associated Transcription Factor","Young Adult"],"keywords":["Germline","Melanoma","Germline mutation","Pathology","Medicine","Mutation","Dermatology","Biology","Genetics","Cancer research","Gene","Melanocytic nevus","Hereditary","Cdkn2a","Adult","Adolescent","Oncology and Carcinogenesis","Clinical Sciences","Telomere-Binding Proteins","p16","Shelterin Complex","Young Adult","Rare Diseases","Pigmented","80 and over","2.1 Biological and endogenous factors","Humans","Genetic Predisposition to Disease","Genetic Testing","Aetiology","Nevus","Telomerase","Cyclin-Dependent Kinase Inhibitor p16","Germ-Line Mutation","Cancer","Aged","Aged, 80 and over","Microphthalmia-Associated Transcription Factor","Nevus, Pigmented","Biomedical and Clinical Sciences","Dermatology & Venereal Diseases","Genes, p16","Tumor Suppressor Proteins","Cyclin-Dependent Kinase 4","Middle Aged","Phenotype","Genes","Melanocortin","Ubiquitin Thiolesterase","Receptor, Melanocortin, Type 1","Receptor","Type 1"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-07T22:42:43.850594Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}